Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, exhibits promising results in research studies. By activating these https://heidigwae939959.tribunablog.com/tirzepatide-a-promising-new-treatment-for-obesity-50570649